INTERNATIONAL PATENT: GENECENTRIC THERAPEUTICS, INC. FILES APPLICATION FOR "THERAPEUTIC PREDICTIVE RESPONSE SIGNATURES AND USES THEREOF IN CANCER PATIENTS"

GENEVA, Dec. 24 -- GENECENTRIC THERAPEUTICS, INC. (6 Davis Drive, Suite 146Durham, North Carolina 27709) filed a patent application (PCT/US2025/032861) for "THERAPEUTIC PREDICTIVE RESPONSE SIGNATURES AND USES THEREOF IN CANCER PATIENTS" on Jun 09, 2025. With publication no. WO/2025/259592, the details related to the patent application was published on Dec 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MAYHEW, Gregory Michael (c/o GeneCentric Therapeutics, Inc.6 Davis Drive, Suite 146Durham, North Carolina 27709), DAVISON, James Mancil (c/o GeneCentric Therapeutics, Inc.6 Davis Drive, Su...